D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 30,243 294 World Ranking 6454 National Ranking 3524

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Disease

David G. Standaert mainly focuses on Neuroscience, Cell biology, Internal medicine, Metabotropic glutamate receptor and Endocrinology. His Neuroscience study frequently draws parallels with other fields, such as Glutamate receptor. His Cell biology study combines topics from a wide range of disciplines, such as Trinucleotide repeat expansion, Microglia, Neuroinflammation, Pars compacta and Proinflammatory cytokine.

David G. Standaert has researched Internal medicine in several fields, including Gene expression, Gene expression profiling and Atriopeptins. As part of the same scientific family, he usually focuses on Endocrinology, concentrating on NMDA receptor and intersecting with Dopamine. He works mostly in the field of Levodopa, limiting it down to topics relating to Anesthesia and, in certain cases, Disease, as a part of the same area of interest.

His most cited work include:

  • Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial (793 citations)
  • The Parkinson Progression Marker Initiative (PPMI) (745 citations)
  • Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease (617 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Neuroscience, Parkinson's disease, Internal medicine, Disease and Endocrinology. When carried out as part of a general Parkinson's disease research project, his work on Dyskinesia, Levodopa and Levodopa carbidopa is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His specific area of interest is Internal medicine, where David G. Standaert studies Progressive supranuclear palsy.

His Disease research integrates issues from Biomarker, Physical therapy and Clinical trial, Bioinformatics. David G. Standaert studies Dopaminergic which is a part of Endocrinology. His Substantia nigra research includes elements of Molecular biology and Cell biology.

He most often published in these fields:

  • Neuroscience (27.62%)
  • Parkinson's disease (25.87%)
  • Internal medicine (24.13%)

What were the highlights of his more recent work (between 2016-2021)?

  • Parkinson's disease (25.87%)
  • Disease (16.78%)
  • Internal medicine (24.13%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Parkinson's disease, Disease, Internal medicine, Neuroscience and Progressive supranuclear palsy. His study in Parkinson's disease is interdisciplinary in nature, drawing from both Anesthesia and Observational study. David G. Standaert combines subjects such as Confounding, Clinical trial and Immunology, Pathogenesis with his study of Disease.

The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Neurology and Rating scale. His research on Endocrinology focuses in particular on Dopaminergic. His Neuroscience study frequently links to other fields, such as Precision medicine.

Between 2016 and 2021, his most popular works were:

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy (246 citations)
  • Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. (79 citations)
  • Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. (70 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Disease

His scientific interests lie mostly in Parkinson's disease, Disease, Neuroscience, Internal medicine and Adverse effect. His Parkinson's disease research is multidisciplinary, incorporating elements of Neuroprotection, Drug and Pharmacology. His research in Disease intersects with topics in Clinical trial, Pathogenesis, Postmortem studies, Neurology and Confounding.

His Neuroscience study often links to related topics such as Precision medicine. The study of Internal medicine is intertwined with the study of Endocrinology in a number of ways. His biological study deals with issues like Dyskinesia, which deal with fields such as Anesthesia and Movement disorders.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott.
JAMA (2000)

1260 Citations

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)

1097 Citations

Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease

Anthone W. Dunah;Hyunkyung Jeong;April Griffin;Yong Man Kim.
Science (2002)

812 Citations

Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors

S. Patel;K. Lorincz;R. Hughes;N. Huggins.
international conference of the ieee engineering in medicine and biology society (2009)

652 Citations

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

J.-F. Chen;Zhihong Huang;Jianya Ma;Jinmin Zhu.
The Journal of Neuroscience (1999)

641 Citations

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Robert G Holloway;Ira Shoulson;Stanley Fahn;Karl Kieburtz.
JAMA Neurology (2004)

634 Citations

Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat

CM Testa;DG Standaert;AB Young;JB Penney.
The Journal of Neuroscience (1994)

588 Citations

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

C Warren Olanow;Karl Kieburtz;Per Odin;Alberto J Espay.
Lancet Neurology (2014)

588 Citations

Molecular markers of early Parkinson's disease based on gene expression in blood

Clemens R. Scherzer;Clemens R. Scherzer;Aron C. Eklund;Lee J. Morse;Zhixiang Liao.
Proceedings of the National Academy of Sciences of the United States of America (2007)

543 Citations

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe.
Movement Disorders (2017)

540 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David G. Standaert

Yoland Smith

Yoland Smith

Emory University

Publications: 100

Werner Poewe

Werner Poewe

Innsbruck Medical University

Publications: 76

Anthony E. Lang

Anthony E. Lang

University of Toronto

Publications: 75

Jiang-Fan Chen

Jiang-Fan Chen

Boston University

Publications: 73

Paolo Calabresi

Paolo Calabresi

Catholic University of the Sacred Heart

Publications: 68

John Q. Wang

John Q. Wang

University of Missouri–Kansas City

Publications: 62

Daniel Weintraub

Daniel Weintraub

University of Pennsylvania

Publications: 62

Erwan Bezard

Erwan Bezard

University of Bordeaux

Publications: 60

Angelo Antonini

Angelo Antonini

University of Padua

Publications: 59

Joseph Jankovic

Joseph Jankovic

Baylor College of Medicine

Publications: 58

Michael A. Schwarzschild

Michael A. Schwarzschild

Harvard University

Publications: 55

Robert A. Hauser

Robert A. Hauser

University of South Florida

Publications: 52

P. Jeffrey Conn

P. Jeffrey Conn

Vanderbilt University

Publications: 52

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 50

Guy A. Caldwell

Guy A. Caldwell

University of Alabama

Publications: 49

Antonio Pisani

Antonio Pisani

University of Rome Tor Vergata

Publications: 48

Trending Scientists

Nikita Andreevich Slavnov

Nikita Andreevich Slavnov

Steklov Mathematical Institute

Liang Zhou

Liang Zhou

Nanjing University of Posts and Telecommunications

John D. Cressler

John D. Cressler

Georgia Institute of Technology

Michel Bierlaire

Michel Bierlaire

École Polytechnique Fédérale de Lausanne

Carsten Dachsbacher

Carsten Dachsbacher

Karlsruhe Institute of Technology

Mikko Hupa

Mikko Hupa

Åbo Akademi University

Richard A. Yost

Richard A. Yost

University of Florida

Henry M. Wilbur

Henry M. Wilbur

University of Virginia

Alexander Grinberg

Alexander Grinberg

National Institutes of Health

Ricardo Antunes Azevedo

Ricardo Antunes Azevedo

Universidade de São Paulo

Ben Fabry

Ben Fabry

University of Erlangen-Nuremberg

Robert H. Mach

Robert H. Mach

University of Pennsylvania

Ioana Agache

Ioana Agache

Transylvania University of Brașov

Filippo Muratori

Filippo Muratori

University of Pisa

Jeffrey F. Peipert

Jeffrey F. Peipert

Indiana University

George F. Dreher

George F. Dreher

Indiana University

Something went wrong. Please try again later.